Formula: | C19H26N4O2 |
Molecular Weight: | 342.44 |
Rotatable Bond Donors: | 4 |
clogP: | 2.03 |
Topological Polar Surface Area: | 52.29 |
Lipinski's RO5: | MW: 342.44 HBA: 6 HBD: 0 RB: 4 LogP: 2.03 |
Rule of Three: | MW: 342.44 HBA: 6 HBD: 0 RB: 4 LogP: 2.03 |
|
ECBD ID | Similarity | Structure | SDF |
---|
ECBD ID | Similarity | Structure | SDF | |
---|---|---|---|---|
EOS17711 | 0.91 | EOS17711 RDKit 3D 28 32 0 0 0 0 0 0 0 0999 V2000 0.7868 1.7592 -1.3044 O 0 0 0 0 0 0 0 0 0 0 0 0 0.1270 0.7322 -1.2867 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.6807 0.2468 -2.3312 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.9075 0.8890 -3.5906 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.7879 2.1071 -3.4397 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.9903 3.3658 -3.6984 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.8323 4.6204 -3.5939 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.3193 4.3520 -3.4941 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.7757 3.2854 -4.4653 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.9651 2.0081 -4.3846 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.3605 -0.8821 -1.8839 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.3120 -1.6589 -2.5024 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.8415 -2.7037 -1.7486 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.3983 -2.8856 -0.4335 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4695 -2.1179 0.1893 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.9686 -1.1414 -0.5746 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.0049 -0.1863 -0.2227 N 0 0 0 0 0 0 0 0 0 0 0 0 0.5130 -0.0130 1.1105 C 0 0 2 0 0 0 0 0 0 0 0 0 1.8860 0.6274 1.1310 C 0 0 0 0 0 0 0 0 0 0 0 0 2.6228 -0.0633 2.2531 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1015 -1.4234 2.2457 N 0 0 0 0 0 0 0 0 0 0 0 0 2.2192 -2.0830 3.5356 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7363 -1.3031 4.7445 C 0 0 0 0 0 0 0 0 0 0 0 0 2.8405 -0.4884 5.3866 C 0 0 0 0 0 0 0 0 0 0 0 0 3.9679 -1.3117 5.6516 O 0 0 0 0 0 0 0 0 0 0 0 0 4.5380 -1.7342 4.4181 C 0 0 0 0 0 0 0 0 0 0 0 0 3.5908 -2.6911 3.7275 C 0 0 0 0 0 0 0 0 0 0 0 0 0.6843 -1.3062 1.8997 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 2 0 2 3 1 0 3 4 1 0 4 5 1 0 5 6 1 0 6 7 1 0 7 8 1 0 8 9 1 0 9 10 1 0 3 11 1 0 11 12 2 0 12 13 1 0 13 14 2 0 14 15 1 0 15 16 2 0 16 17 1 0 18 17 1 6 18 19 1 0 19 20 1 0 20 21 1 0 21 22 1 0 22 23 1 0 23 24 1 0 24 25 1 0 25 26 1 0 26 27 1 0 21 28 1 0 17 2 1 0 28 18 1 0 10 5 1 0 16 11 1 0 27 22 1 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
GPR35 antagonism | primary assay | G-protein coupled receptor 35 | inactive |